McKesson Corporation logo
McKesson Corporation MCK
$ 813.63 -0.23%

Quarterly report 2025-Q2
added 08-06-2025

report update icon

McKesson Corporation Financial Ratios 2011-2025 | MCK

Annual Financial Ratios McKesson Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-9.0 28.4 687.4 485.0 6.0 17.1 35.1 30.7 18.6 16.0 17.8

P/S

0.2 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.2 0.2 0.2

EPS

-28.3 5.0 0.2 0.3 22.9 9.8 6.4 5.5 5.7 5.7 4.7

EV (Enterprise Value)

34.7 B 77.5 B 71.8 B 80.1 B 77.5 B 82.1 B 92.3 B 76 B 50.1 B 45.6 B 41.5 B

EBITDA per Share

-29.2 20.3 21.6 18.6 19.8 20.1 17.8 13.7 12.3 11.6 8.42

EV/EBITDA

-7.4 7.9 6.6 9.7 8.3 9.2 13.6 14.4 9.4 8.2 10.0

PEG

0.19 0.01 -14.9 -4.92 0.05 0.32 2.25 -8.76 105.94 0.71 -16.75

P/B

0.6 5.0 2.9 3.3 2.8 4.3 6.5 4.5 3.5 3.3 3.0

P/CF

9.0 6.6 6.7 8.6 7.3 12.9 20.2 14.2 12.0 8.8 11.0

ROE %

21614.29 17.67 0.42 0.68 45.70 25.30 18.45 14.82 18.93 20.54 16.65

ROA %

-6.98 1.47 0.06 0.11 8.32 3.99 2.74 2.44 3.85 4.24 3.89

ROCE %

24000.00 14.82 14.88 12.33 13.66 17.44 15.30 10.94 17.17 20.15 16.73

Current Ratio

- 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.2

DSO

30.0 31.5 31.1 31.0 33.5 34.4 32.4 37.6 29.7 29.7 29.9

DIO

29.0 27.9 30.1 30.2 29.8 31.2 31.1 37.6 32.7 31.6 31.7

DPO

61.5 62.0 61.0 59.6 60.5 58.1 54.8 60.5 50.9 50.6 -

Operating Cycle

59.0 59.4 61.2 61.2 63.3 65.6 63.6 75.2 62.4 61.3 61.6

Cash Conversion Cycle

-2.5 -2.6 0.2 1.7 2.8 7.4 8.8 14.7 11.5 10.7 61.6

All numbers in USD currency

Quarterly Financial Ratios McKesson Corporation

2025-Q2 2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

6.28 1.88 7.04 4.95 7.07 - - - 5.32 - -0.04 4.85 4.85 4.19 -39.03 -39.03 3.56 2.74 1.04 1.04 -3.99 2.25 2.41 2.41 2.52 -5.58 4.35 0.01 1.46 1.46 2.87 2.87 1.36 2.41 2.76 2.76 2.66 2.49 2.03 2.03 2.02 1.75 0.28 0.28 1.76 1.86 1.27 1.27 1.7 1.61 1.22 1.22 1.2 1.15

EBITDA per Share

9.55 4.96 9.23 7.55 8.59 - - - 7.61 - 2.49 10.5 8.09 - -45.5 -44.7 4.86 4.65 2.65 5.87 5.95 3.97 4.15 7.2 5.88 - 4.62 1.75 4.08 - 4.22 13.6 8.9 - 4.47 15.1 10.1 - 3.99 13.2 8.68 - 2.45 10.2 7.34 - 2.34 8.74 6.08 - 2.2 7.49 4.94 -

ROE %

-159.46 -196.86 -188.87 -122.61 -129.43 -104.35 -103.80 -51.08 -181.72 -272.44 -3443.87 -2139.18 -2114.24 -1961.30 1218.85 -83.38 25.20 5.33 1.84 3.93 6.09 20.67 3.75 6.34 1.32 -1.25 13.22 13.76 20.45 21.03 24.32 23.23 23.75 27.40 28.53 26.58 24.65 22.90 20.43 16.05 11.58 11.81 13.07 16.16 19.21 19.32 18.89 19.02 19.37 18.08 16.48 4.22 4.28 3.96

ROA %

4.07 4.60 4.27 1.49 1.49 - -0.01 -0.02 1.15 2.36 3.38 -6.67 -17.96 -18.16 -18.46 -8.08 2.35 0.16 0.15 0.61 1.06 3.06 0.45 1.09 0.32 0.01 2.41 2.10 3.19 3.22 3.67 3.73 3.78 4.35 4.46 4.16 3.93 3.71 3.42 2.75 2.02 2.28 2.72 3.43 4.15 4.28 4.21 4.22 4.26 3.95 3.73 0.94 0.95 0.93

ROCE %

-211.30 -247.34 -228.18 -153.67 -159.09 -140.76 -164.15 -117.16 -363.22 -478.71 1064.68 2631.47 2752.54 1430.05 1443.36 -94.20 36.34 32.65 27.17 28.77 30.54 29.92 29.19 28.86 23.68 14.85 25.66 29.35 52.43 52.80 63.17 62.73 69.43 63.58 72.38 70.82 64.30 50.55 56.69 54.03 51.59 47.20 53.71 54.08 52.90 44.70 51.29 51.38 49.87 40.60 6.60 20.26 13.73 -

DSO

24.9 23.9 - - 25.3 - - - 12.6 - 25.6 9.3 13.9 29.4 27.8 27.0 28.3 31.8 29.2 29.5 29.7 30.4 31.0 31.1 31.6 33.3 33.7 34.0 33.4 34.1 33.2 33.4 33.2 32.5 32.6 31.9 30.5 31.2 31.4 29.8 29.6 25.7 28.0 27.0 27.6 28.2 29.0 28.4 30.0 29.2 28.4 28.0 28.0 -

DIO

23.8 25.1 - - 25.7 - - - 13.3 - 26.9 9.6 14.6 - 28.9 26.9 26.3 29.1 27.1 26.8 27.8 29.0 28.8 28.3 29.6 - 30.5 30.0 29.0 - 30.3 9.9 15.0 - 32.4 10.3 14.7 - 30.8 10.2 15.1 - 30.8 10.1 15.4 - 31.7 10.6 16.1 - 30.9 10.0 15.0 -

DPO

53.6 53.0 - - 55.2 - - - 27.1 - 53.3 18.8 28.7 - 55.8 53.3 55.6 60.2 53.1 54.1 56.6 56.8 56.0 56.0 58.3 - 59.7 60.8 59.3 - 59.6 19.8 28.6 - 54.7 18.0 25.9 - 50.1 16.5 24.4 - 46.5 16.1 24.4 - 47.3 16.1 24.9 - 47.6 15.6 22.9 -

Operating Cycle

48.7 49.0 - - 51.0 - - - 25.9 - 52.5 18.9 28.5 29.4 56.7 53.9 54.6 60.9 56.3 56.3 57.5 59.5 59.8 59.4 61.3 33.3 64.2 64.0 62.3 34.1 63.5 43.3 48.1 32.5 65.0 42.2 45.2 31.2 62.2 40.0 44.7 25.7 58.8 37.1 43.0 28.2 60.7 39.0 46.0 29.2 59.3 38.0 43.0 -

Cash Conversion Cycle

-5.0 -4.0 - - -4.3 - - - -1.2 - -0.8 0.1 -0.2 29.4 0.9 0.6 -1.0 0.6 3.2 2.2 0.9 2.6 3.8 3.5 3.0 33.3 4.5 3.2 3.0 34.1 3.9 23.4 19.5 32.5 10.3 24.2 19.3 31.2 12.1 23.5 20.3 25.7 12.4 21.1 18.6 28.2 13.4 22.9 21.1 29.2 11.6 22.4 20.1 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company McKesson Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical distribution industry

Issuer Price % 24h Market Cap Country
AmerisourceBergen Corporation AmerisourceBergen Corporation
ABC
- -0.23 % $ 37.5 B usaUSA
Cardinal Health Cardinal Health
CAH
$ 197.81 -0.26 % $ 47.7 B usaUSA
PPD, Inc. PPD, Inc.
PPD
- 0.13 % $ 16.6 B usaUSA
Prestige Consumer Healthcare Prestige Consumer Healthcare
PBH
$ 61.48 1.01 % $ 3.06 B usaUSA
Patterson Companies Patterson Companies
PDCO
- -0.87 % $ 3 B usaUSA
Henry Schein Henry Schein
HSIC
$ 76.48 0.31 % $ 9.7 B usaUSA
Owens & Minor Owens & Minor
OMI
$ 3.06 3.56 % $ 235 M usaUSA